A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-016-1434-x
Published Online: 2016-07-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Karch, Annika
Koch, Armin
Grünwald, Viktor